Race Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 09-12-2024
- Satisfied Charges ₹ 1.50 Cr
as on 09-12-2024
- Revenue 13.53%
(FY 2022)
- Profit 13.63%
(FY 2022)
- Ebitda 42.63%
(FY 2022)
- Net Worth 10.52%
(FY 2022)
- Total Assets 137.49%
(FY 2022)
About Race Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Natarajan Kumaran and Menaga Kumaran serve as directors at the Company.
- CIN/LLPIN
U02423TN2007PTC061928
- Company No.
061928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Race Pharmaceuticals Private Limited offer?
Race Pharmaceuticals Private Limited offers a wide range of products and services, including Antibacterial Drugs, Antibiotic Tablets & Capsules, Azithromycin Tablets, Multivitamin Tablets & Capsules, Gastrointestinal Drugs, Antiemetic Drugs, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Health Conditions, Liver Care.
Who are the key members and board of directors at Race Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Natarajan Kumaran  | Director | 03-Jan-2007 | Current |
| Menaga Kumaran | Director | 03-Jan-2007 | Current |
Financial Performance of Race Pharmaceuticals.
Race Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.53% increase. The company also saw a substantial improvement in profitability, with a 13.63% increase in profit. The company's net worth Soared by an impressive increase of 10.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Race Pharmaceuticals?
In 2022, Race Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Oct 2024 | ₹8,000.00 | Open |
Others Creation Date: 06 Oct 2016 | ₹2.00 Cr | Open |
Others Creation Date: 05 Aug 2013 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Race Pharmaceuticals?
Race Pharmaceuticals has a workforce of 37 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Race Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Race Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
